Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

14.72

-0.71 (-4.60%)

At close: Aug 11, 2026, 4:00 PM EDT

14.75

+0.03 (0.20%)

After-hours: Aug 11, 2026, 7:53 PM EDT

Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	72.05	11.28	121.45	68.79	66.32	99.42
Short-Term Investments	-	73.84	26.03	-	19.75	-
Cash & Short-Term Investments	72.05	85.11	147.48	68.79	86.07	99.42
Cash Growth	-36.88%	-42.29%	114.39%	-20.08%	-13.43%	86.74%
Accounts Receivable	-	-	0.97	0.29	1.11	0.45
Other Receivables	9.29	22.01	24.42	22.44	18	9.39
Total Trade Receivables	9.29	22.01	25.39	22.73	19.11	9.84
Other Current Assets	12.94	11.54	14.68	11.63	11.79	7.46
Total Current Assets	94.28	118.66	187.55	103.15	116.97	116.72
Net Property, Plant & Equipment	1.44	1.75	1.98	2.31	2.66	2.63
Other Intangible Assets	0.24	0.29	0.31	0.36	0.39	0.03
Goodwill	10.33	10.62	9.4	9.98	9.69	10.26
Long-Term Investments	-	-	0.36	-	0.34	0.41
Other Long-Term Assets	0.13	0.13	3.24	3.65	-	-
Total Assets	106.41	131.44	202.83	119.45	130.05	130.05
Accounts Payable	12.61	13.36	16.45	15.54	15.28	14.58
Current Portion of Leases	0.1	0.09	0.12	0.23	0.54	0.19
Unearned Revenue	-	0.17	0.31	6.57	10.72	5.74
Total Current Liabilities	12.71	13.61	16.87	22.34	26.55	20.51
Long-Term Leases	0.01	0.07	-	0.12	-	-
Other Long-Term Liabilities	55.22	55.45	51.84	75	-	-
Total Long-Term Liabilities	55.23	55.53	51.84	75.12	-	-
Total Liabilities	67.94	69.14	68.72	97.46	26.55	20.51
Common Stock	-10.29	-10.29	8.89	-8.85	6.52	6.07
Additional Paid-in Capital	-621.15	-617.56	546.51	-455.77	336.15	304.82
Accumulated Other Comprehensive Income	3.34	2.98	2.08	10.73	-	-
Retained Earnings	589.63	562.57	-423.36	431.89	-318.5	-301.45
Shareholders' Equity	-38.47	-62.3	134.12	-21.99	26.7	11.53
Total Liabilities & Equity	106.41	131.44	202.83	119.45	53.25	32.03
Total Debt	0.11	0.16	0.12	0.35	0.54	0.19
Net Cash (Debt)	71.94	84.95	147.36	68.44	85.53	99.24
Net Cash Growth	-36.98%	-42.35%	115.31%	-19.98%	-13.81%	88.04%
Net Cash Per Share	1.52	1.80	3.19	1.84	2.66	3.35
Book Value	-38.47	-62.3	134.12	-21.99	26.7	11.53
Book Value Per Share	-0.81	-1.32	2.90	-0.59	0.83	0.39
Tangible Book Value	-49.03	-73.21	124.41	-32.34	16.63	1.23
Tangible Book Value Per Share	-1.04	-1.55	2.69	-0.87	0.52	0.04

SEC Filings: 10-K · 10-Q